Evidence map›Paper›PMID 34685665›Full record

ReviewCells2021

Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned.

Lorenzo Belluomini, Silvia Teresa Riva, Michele Simbolo, Riccardo Nocini, Ilaria Trestini, Alice Avancini, Daniela Tregnago, Miriam Grazia Ferrara, Alberto Caldart, Alessandra Dodi and 6 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Lorenzo BelluominiSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.ORCID 0000-0003-1981-5499
Silvia Teresa RivaSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.
Michele SimboloSection of Pathology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-0866-4499
Riccardo NociniOtolaryngology-Head and Neck Surgery Department, University of Verona Hospital Trust, 37126 Verona, Italy.
Ilaria TrestiniSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.ORCID 0000-0002-4958-9771
Alice AvanciniSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.ORCID 0000-0003-2439-4799
Daniela TregnagoSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.
Miriam Grazia FerraraComprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00100 Rome, Italy.ORCID 0000-0002-3678-2599
Alberto CaldartSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.
Alessandra DodiSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.
Anna CaliòSection of Pathology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.
Emilio BriaComprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00100 Rome, Italy.ORCID 0000-0002-2333-704X
Aldo ScarpaSection of Pathology, Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.ORCID 0000-0003-1678-739X
Michele MilellaSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.
Jessica MenisSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.
Sara PilottoSection of Oncology, Department of Medicine, University of Verona Hospital Trust, 37134 Verona, Italy.ORCID 0000-0003-2229-4874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsClinical Trials as TopicErbB ReceptorsHumansLung NeoplasmsNeoadjuvant TherapyNeoplasm StagingPatient SelectionErbB ReceptorsADAURAearly profilingearly stageEGFRNSCLC

Identifiers

PMID34685665
PMCPMC8535007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.